Neogen Corporation Operating Income 2011-2026 | NEOG

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Neogen Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-1.06 B	58.7 M	37.5 M	58.6 M	74.2 M	67.5 M	68.1 M	70.2 M	64.9 M	56.4 M	53.1 M	43.4 M	40.7 M	33.7 M	35.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
74.2 M	-1.06 B	-19.9 M

Quarterly Operating Income Neogen Corporation

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-5.38 M	-16.1 M	-	5.42 M	-457 M	2.26 M	-	12 M	14.5 M	19.1 M	-	15.7 M	-7.66 M	6.06 M	-1.59 M	6.38 M	12.5 M	21.7 M	34.2 M	15.8 M	19.2 M	18.9 M	19.2 M	13 M	18.3 M	16.3 M	18.3 M	16.3 M	18.2 M	16.5 M	18.2 M	16.5 M	18 M	16.4 M	18 M	16.4 M	16.9 M	14.7 M	16.9 M	14.7 M	14.6 M	14.9 M	14.6 M	12.2 M	12.9 M	13.4 M	12.9 M	13.4 M	9.69 M	12.4 M	9.69 M	12.4 M	10.5 M	10.3 M	10.5 M	10.3 M	8.14 M	9.35 M	8.14 M	9.35 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
34.2 M	-457 M	4.35 M

Operating Income of other stocks in the Diagnostics research industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-46 M	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	-28.1 M	-	-17.87 %	$ 25.9 M	Canada
BioNano Genomics BNGO	-104 M	$ 1.16	3.12 %	$ 1.47 M	USA
Brainsway Ltd. BWAY	-5 M	$ 24.37	-0.16 %	$ 99.4 M	Israel
Burning Rock Biotech Limited BNR	-797 M	$ 26.8	-3.0 %	$ 297 M	China
Aspira Women's Health AWH	-32.8 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-14 M	-	-61.36 %	$ 2.46 M	USA
Celcuity CELC	-113 M	$ 108.23	2.31 %	$ 4.27 B	USA
Biocept BIOC	-32 M	-	-13.05 %	$ 7.29 M	USA
Check-Cap Ltd. CHEK	-25.9 M	-	-	$ 9.42 M	Israel
Danaher Corporation DHR	4.69 B	$ 209.64	0.22 %	$ 149 B	USA
DarioHealth Corp. DRIO	-56.2 M	$ 11.26	-	$ 319 M	Israel
Chembio Diagnostics CEMI	-23.6 M	-	0.22 %	$ 16.8 M	USA
Enzo Biochem ENZ	-12.4 M	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	-42.7 M	-	-	$ 79.8 M	USA
Fulgent Genetics FLGT	-73.9 M	$ 23.42	1.43 %	$ 708 M	USA
Global Cord Blood Corporation CO	609 M	-	-	$ 399 M	China
Genetron Holdings Limited GTH	-518 M	-	0.12 %	$ 80.1 M	China
Quest Diagnostics Incorporated DGX	1.35 B	$ 209.3	-0.11 %	$ 23.2 B	USA
Castle Biosciences CSTL	8.67 M	$ 30.44	1.67 %	$ 846 M	USA
CareDx, Inc CDNA	-203 M	$ 17.63	-8.42 %	$ 948 M	USA
DermTech DMTK	-104 M	-	-11.32 %	$ 2.94 M	USA
DexCom DXCM	912 M	$ 72.79	-0.41 %	$ 28.4 B	USA
Interpace Biosciences IDXG	8.11 M	$ 1.74	-5.95 %	$ 7.63 M	USA
Exact Sciences Corporation EXAS	-206 M	$ 103.39	-0.06 %	$ 19.5 B	USA
Laboratory Corporation of America Holdings LH	1.38 B	$ 285.93	-0.42 %	$ 23.8 B	USA
Guardant Health GH	-437 M	$ 95.36	-0.04 %	$ 12 B	USA
QIAGEN N.V. QGEN	97.7 M	-	-	$ 10.6 B	Niderland
Charles River Laboratories International CRL	25.2 M	$ 170.5	2.67 %	$ 8.45 B	USA
Heska Corporation HSKA	-20.3 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-20.8 M	-	-20.0 %	$ 1.06 M	USA
Myriad Genetics MYGN	-387 M	$ 4.61	4.06 %	$ 427 M	USA
ICON Public Limited Company ICLR	1.1 B	$ 103.45	-0.61 %	$ 8.53 B	Irlanda
ENDRA Life Sciences NDRA	-10.8 M	$ 3.5	-9.32 %	$ 1.88 M	USA
IDEXX Laboratories IDXX	1.36 B	$ 660.2	1.69 %	$ 53.1 B	USA
Illumina ILMN	-833 M	$ 123.23	0.26 %	$ 19.6 B	USA
Natera NTRA	-541 M	$ 209.8	0.13 %	$ 20.6 B	USA
IQVIA Holdings IQV	2.18 B	$ 163.11	-1.07 %	$ 28 B	USA
Motus GI Holdings MOTS	-11.9 M	-	-34.28 %	$ 263 K	Israel
Pacific Biosciences of California PACB	-334 M	$ 1.7	2.11 %	$ 431 M	USA
Biodesix BDSX	-34.5 M	$ 13.3	2.15 %	$ 1.72 B	USA
Koninklijke Philips N.V. PHG	553 M	$ 31.48	-0.06 %	$ 20 B	Niderland
Lantheus Holdings LNTH	457 M	$ 74.86	1.7 %	$ 5.18 B	USA
Biomerica BMRA	-5.14 M	$ 2.1	-	$ 4.82 M	USA